tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Certara reports Q2 adjusted EPS 7c, consensus 10c

Reports Q2 revenue $104.6M, consensus $104.08M. “Our commercial team has continued to field significant interest from customers seeking to expand their use of model-informed drug development,” said William Feehery, CEO. “We are excited about software product enhancements and new product introductions that will expand our market leading offering and deliver sustainable long-term growth.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1